Molecular Partners Ag (MOLN) Share-based Compensation (2020 - 2026)

Molecular Partners Ag (MOLN) has reported Share-based Compensation for 7 consecutive years, with $1195.3 the latest figure, recorded in Q1 2026.

• Quarterly Share-based Compensation fell 5.9% year-over-year to $1195.3 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.1 million (up 11.07% YoY) and the FY2025 annual result came in at $5.5 million, up 17.99% from the prior year.
• Share-based Compensation retreated to $1195.3 in Q1 2026 per MOLN's latest filing, from $5.5 million in the prior quarter.
• Over the last five years, Share-based Compensation for MOLN reached as high as $5.9 million in Q4 2023 and fell as low as -$3.5 million in Q3 2023.
• A 5-year average of $909222.3 and a median of $1888.8 in 2023 frame the typical range for Share-based Compensation.
• Annual changes were most pronounced in 2022 — Share-based Compensation surged 67.26% — and 2024, when it slumped 48.2%.
• Year by year, Share-based Compensation stood at $5.3 million in 2022, then gained by 11.15% to $5.9 million in 2023, then retreated by 20.17% to $4.7 million in 2024, then climbed by 17.98% to $5.5 million in 2025, then tumbled by 99.98% to $1195.3 in 2026.
• According to Business Quant data, Share-based Compensation over the past three periods registered $1195.3, $5.5 million, and -$3.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.